Document Detail


Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.
MedLine Citation:
PMID:  17088459     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Nearly half of patients with heart failure have a preserved ejection fraction (HFpEF). Symptoms of exercise intolerance and dyspnea are most often attributed to diastolic dysfunction; however, impaired systolic and/or arterial vasodilator reserve under stress could also play an important role. METHODS AND RESULTS: Patients with HFpEF (n=17) and control subjects without heart failure (n=19) generally matched for age, gender, hypertension, diabetes mellitus, obesity, and the presence of left ventricular hypertrophy underwent maximal-effort upright cycle ergometry with radionuclide ventriculography to determine rest and exercise cardiovascular function. Resting cardiovascular function was similar between the 2 groups. Both had limited exercise capacity, but this was more profoundly reduced in HFpEF patients (exercise duration 180+/-71 versus 455+/-184 seconds; peak oxygen consumption 9.0+/-3.4 versus 14.4+/-3.4 mL x kg(-1) x min(-1); both P<0.001). At matched low-level workload, HFpEF subjects displayed approximately 40% less of an increase in heart rate and cardiac output and less systemic vasodilation (all P<0.05) despite a similar rise in end-diastolic volume, stroke volume, and contractility. Heart rate recovery after exercise was also significantly delayed in HFpEF patients. Exercise capacity correlated with the change in cardiac output, heart rate, and vascular resistance but not end-diastolic volume or stroke volume. Lung blood volume and plasma norepinephrine levels rose similarly with exercise in both groups. CONCLUSIONS: HFpEF patients have reduced chronotropic, vasodilator, and cardiac output reserve during exercise compared with matched subjects with hypertensive cardiac hypertrophy. These limitations cannot be ascribed to diastolic abnormalities per se and may provide novel therapeutic targets for interventions to improve exercise capacity in this disorder.
Authors:
Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Related Documents :
7469209 - Exercise left ventricular performance in patients with chest pain, ischemic-appearing e...
7031609 - About the possibilities of registration of drug influence by means of radiocardiographi...
2452309 - Effect of intravenous digoxin on the heart at rest and during isometric exercise: a non...
6690559 - Mechanism and significance of a decrease in ejection fraction during exercise in patien...
21094369 - Relation of size of secondary ventricles to exercise performance in children after font...
15629509 - Cardiac alterations in cirrhosis: reversibility after liver transplantation.
11744659 - Influence of prior exercise and liver glycogen content on the sensitivity of the liver ...
23635309 - Comparing effects of low- and high-volume moderate-intensity exercise on sexual functio...
596209 - Low intensity training, inactivity and resumed training in sedentary men.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-11-06
Journal Detail:
Title:  Circulation     Volume:  114     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-11-14     Completed Date:  2006-12-01     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2138-47     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Autonomic Nervous System / physiopathology
Blood Volume
Cardiac Output
Cardiac Output, Low / physiopathology*
Epinephrine / blood
Exercise
Exercise Test
Female
Heart Rate*
Humans
Male
Middle Aged
Norepinephrine / blood
Physical Endurance*
Pulmonary Circulation
Stroke Volume*
Vasodilation*
Grant Support
ID/Acronym/Agency:
R01-AG18324/AG/NIA NIH HHS; T32-HL07227/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
51-41-2/Norepinephrine; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surger...
Next Document:  Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor...